Cargando…

Drug Design and Development for Rare Hematologic Diseases

Detalles Bibliográficos
Autores principales:	Fattizzo, Bruno, Capecchi, Marco, Motta, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609818/ https://www.ncbi.nlm.nih.gov/pubmed/37895940 http://dx.doi.org/10.3390/ph16101469

Ejemplares similares

Rise of the planet of rare anemias: An update on emerging treatment strategies
por: Fattizzo, Bruno, et al.
Publicado: (2023)

Innovative Treatments for Rare Anemias
por: Cappellini, Maria Domenica, et al.
Publicado: (2021)

Hematological and Extra-Hematological Autoimmune Complications after Checkpoint Inhibitors
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)

Drug Resistance in Hematological Malignancies
por: Auberger, Patrick, et al.
Publicado: (2020)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

Vaccinations in hematological patients in the era of target therapies: Lesson learnt from SARS-CoV-2
por: Fattizzo, Bruno, et al.
Publicado: (2023)

China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year
por: Wang, Xiaochen
Publicado: (2022)

Rare diseases and expensive drugs
por: Katelaris, Constance H.
Publicado: (2014)

Role of Computer-Aided Drug Design in Drug Development
por: Gu, Ruoxu, et al.
Publicado: (2023)

Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics
por: Zhan, Fenghuang, et al.
Publicado: (2015)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Adaptive design – An innovative tool in drug development
por: Brahmachari, Ballari, et al.
Publicado: (2011)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Introducing Mediterranean Journal of Hematology and Infectious Diseases
por: Leone, Giuseppe, et al.
Publicado: (2009)

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature
por: Capecchi, Marco, et al.
Publicado: (2021)

Innovation for rare diseases and bioethical concerns: A thin thread between medical progress and suffering
por: Tommasini, Alberto, et al.
Publicado: (2018)

Clinical Hematology International: Why a New Journal in Hematology?
por: Mohty, Mohamad, et al.
Publicado: (2019)

Development of Medicines for Rare Pediatric Diseases
por: Marimpietri, Danilo, et al.
Publicado: (2023)

Best of hematology—2021
por: Prochazka, Katharina Theresa
Publicado: (2023)

Standardization in hematology and wine
por: McCann, Shaun
Publicado: (2023)

Diversity in hematology research
por: De Paula, Erich V
Publicado: (2023)

BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
por: Chap, Christna
Publicado: (2013)

Rare pulmonary disease and orphan drugs: a path to the future
por: Harari, Sergio, et al.
Publicado: (2019)

Designer drugs
por: Pesce, Amadeo J, et al.
Publicado: (2023)

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
por: Harari, Sergio, et al.
Publicado: (2015)

Immune Microenvironment in Hematologic Malignancies
por: Arandi, Nargess, et al.
Publicado: (2023)

Unanswered Questions in HIV Hematology
por: Leitch, Heather A., et al.
Publicado: (2012)

Blood Research: hematology and beyond
por: Stroncek, David F.
Publicado: (2013)

Here to Stay: Biosimilars in Hematology
por: Gribben, John, et al.
Publicado: (2019)

Nursing in patients with hematological malignancies
por: Geres, Hana, et al.
Publicado: (2020)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

Molecular Immunology in Hematological Disorders
por: Takami, Akiyoshi
Publicado: (2022)

Editorial to the Special Issue “MicroRNA in Solid Tumor and Hematological Diseases”
por: Lovat, Francesca
Publicado: (2021)

Orphanet Journal of Rare Diseases: Launch Editorial
por: Aymé, Ségolène, et al.
Publicado: (2006)

Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
por: Tutone, Marco, et al.
Publicado: (2021)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Advances in Drug Design and Development for Human Therapeutics Using Artificial Intelligence—I
por: Wei, Dongqing, et al.
Publicado: (2022)

Acknowledgment to the Reviewers of Hematology Reports in 2022
Publicado: (2023)

Molecular-Targeted Therapies for Hematologic Malignancies
por: Bunting, Kevin D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_muc6tic6ob58clp1o21ig4dmhv